Correction of β‐thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients
Open Access
- 4 August 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in EMBO Molecular Medicine
- Vol. 2 (8), 315-328
- https://doi.org/10.1002/emmm.201000083
Abstract
β‐Thalassemia is a common monogenic disorder due to mutations in the β‐globin gene and gene therapy, based on autologous transplantation of genetically corrected haematopoietic stem cells (HSCs), holds the promise to treat patients lacking a compatible bone marrow (BM) donor. We recently showed correction of murine β‐thalassemia by gene transfer in HSCs with the GLOBE lentiviral vector (LV), expressing a transcriptionally regulated human β‐globin gene. Here, we report successful correction of thalassemia major in human cells, by studying a large cohort of pediatric patients of diverse ethnic origin, carriers of different mutations and all candidates to BM transplantation. Extensive characterization of BM‐derived CD34+ cells before and following gene transfer shows the achievement of high frequency of transduction, restoration of haemoglobin A synthesis, rescue from apoptosis and correction of ineffective erythropoiesis. The procedure does not significantly affect the differentiating potential and the relative proportion of haematopoietic progenitors. Analysis of vector integrations shows preferential targeting of transcriptionally active regions, without bias for cancer‐related genes. Overall, these results provide a solid rationale for a future clinical translation. See accompanying article: http://dx.doi.org/10.1002/emmm.201000086Keywords
This publication has 50 references indexed in Scilit:
- Plans for London 'Cathedral Of Science' UnveiledScience, 2009
- The 3′ Region of the Chicken Hypersensitive Site-4 Insulator Has Properties Similar to Its Core and Is Required for Full Insulator ActivityPLOS ONE, 2009
- Mechanism of Reduction in Titers From Lentivirus Vectors Carrying Large Inserts in the 3′LTRMolecular Therapy, 2009
- Gene Therapy Continues to Mature and to Face ChallengesMolecular Therapy, 2009
- Optimized Lentiviral Vector Design Improves Titer and Transgene Expression of Vectors Containing the Chicken β-Globin Locus HS4 Insulator ElementMolecular Therapy, 2009
- Transcription Factor Binding Sites Are Genetic Determinants of Retroviral Integration in the Human GenomePLOS ONE, 2009
- In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of β-thalassemiaProceedings of the National Academy of Sciences of the United States of America, 2008
- Novel definition files for human GeneChips based on GeneAnnotBMC Bioinformatics, 2007
- Genome-wide analysis of retroviral DNA integrationNature Reviews Microbiology, 2005
- Globin Chain Synthesis Analysis by High Performance Liquid Chroniatography in the Screening of Thalassemia SyndromesHemoglobin, 1998